 |
Previous Article | Next Article 
Volume 17, Number 12,
Issue of June 15, 1997
pp. 4734-4743
Copyright ©1997 Society for Neuroscience
Neurexin Is Expressed on Nerves, But Not at Nerve Terminals, in
the Electric Organ
Anthony B. Russell and
Steven S. Carlson
Department of Physiology and Biophysics, University of Washington,
Seattle, Washington 98195
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Neurexins are highly variable transmembrane proteins hypothesized
to be nerve terminal-specific cell adhesion molecules. As a test of the
hypothesis that neurexin is restricted to the nerve terminal, we
examined neurexins in the electric organ of the elasmobranch electric
fish. Specific antibodies generated against the intracellular domain of
electric fish neurexin were used in immunocytochemical and Western blot
analyses of the electromotor neurons that innervate the electric organ.
Our results indicate that neurexin is not expressed at electric organ
nerve terminals, as expected by the neurexin hypothesis. Instead,
neurexin is expressed by electromotor neurons and on myelinated axons.
This neurexin has a molecular weight of 140 kDa, consistent with an
-neurexin. In addition, we find that perineurial cells of the
electromotor nerve also express a neurexin. These cells surround
bundles of axons to form a diffusion barrier and are thought to be a
special form of fibroblast. The results of the study argue against a
universal role for neurexins as nerve terminal-specific proteins but
suggest that neurexins are involved in axon-Schwann cell and
perineurial cell interactions.
Key words:
neurexin;
electric organ;
Torpedo;
Narcine;
electromotor nucleus;
glutathione
S-transferase;
perineurium, Schwann cell
INTRODUCTION
Neurexins constitute a family of related highly
polymorphic proteins, the first of which was identified as the
calcium-dependent -latrotoxin receptor (Ushkaryov et al., 1992 ,
Ushkaryov and Südhof, 1993 ). The -latrotoxin from black widow
spider venom induces massive exocytosis of synaptic vesicles from
presynaptic neurons (Gorio et al., 1978 ). There is in vitro
evidence suggesting that the cytoplasmic domain of neurexin interacts
with the synaptic vesicle protein synaptotagmin (Petrenko et al., 1991 ;
Hata et al., 1993 ; Perin, 1994 ) and with proteins believed to be a part of the docking machinery for vesicles, such as the N-type calcium channel (O'Connor et al., 1993 ). In the rat CNS, immunocytochemical data suggest that neurexins are localized to the nerve terminal (Geppert et al., 1992 ; Ushkaryov et al., 1992 ). The cDNAs for the three
neurexin genes from rat and cow CNS have been fully sequenced
(Ushkaryov et al., 1992 , 1994 ; Ushkaryov and Südhof, 1993 ). The
extracellular domain of the neurexin protein has homology to several
extracellular matrix (ECM) molecules, such as laminin, agrin, and
heparan sulfate proteoglycan (Ushkaryov et al., 1992 ), suggesting a
possible extracellular adhesive function (Petrenko, 1993 ). The
extracellular domain of neurexin exhibits extensive variability because
of alternative splicing and the use of alternate promoters in the three
genes that encode the various neurexins (Ushkaryov et al., 1992 , 1994 ;
Ushkaryov and Südhof, 1993 ).
The hypothesis has been proposed that neurexins are synapse-specific
transmembrane cell adhesion molecules that link a postsynaptic ligand
with intracellular exocytotic machinery molecules of the nerve terminal
(Geppert et al., 1992 ). The high variability of neurexin forms could
reflect the synaptic complexity of the CNS with specific
neurexin-postsynaptic protein interactions found at particular types
of synapses acting as a potential neuronal recognition system (Geppert
et al., 1992 ).
However, there are concerns regarding the neurexin hypothesis. Previous
immunocytochemical data supporting a nerve terminal localization for
neurexin are sparse and limited to two areas of the rat CNS (Geppert et
al., 1992 , Ushkaryov et al., 1992 ). Synaptic structures are unaffected
in Drosophila mutants lacking neurexin (Baumgartner et al.,
1996 ). The role of neurexin as a physiologically relevant receptor for
-latrotoxin has recently been cast in doubt because of the discovery
of a calcium-independent -latrotoxin receptor that does not seem to
be a neurexin (Davletov et al., 1996 , Krasnoperov et al., 1996 ).
The electric organ from the marine elasmobranch electric ray
provides a model to test the neurexin hypothesis. The electric organ is
a relatively simple nervous tissue comprising a homogenous population
of cholinergic neurons, which synapse on a homogenous population of
postsynaptic cells. (Bennet, 1971 ). The neurons that innervate the
electric organ originate from the electromotor nucleus (EMN) in the
medulla, which is anatomically separated from the target tissue
(Bennet, 1971 ). Analysis of the electric organ allows examination of
neurexin from a single synaptic type. The electric organ provides a
rich source of nerve terminals that are readily accessible for
biochemical and immunocytochemical study. One expectation of the
neurexin hypothesis should be that the electric organ contains a single
neurexin form or a simple complement of neurexin forms restricted to
the nerve terminal.
In this paper, we report that neurexin is not present at nerve
terminals but is expressed on myelinated nerves in the elasmobranch electric organ at axon-glial cell boundaries. We also find neurexin to
be expressed by non-neuronal perineurial cells. Our data do not support
the neurexin hypothesis but suggest an entirely different role for
neurexin. Our data suggest that neurexin may be involved in perineurial
cell adhesion and axon-glia interactions.
MATERIALS AND METHODS
PCR cloning and fusion protein generation. Degenerate
primers based on the highly conserved C terminus of rat and cow
neurexins (Ushkaryov et al., 1992 , 1994 ; Ushkaryov and Südhof,
1993 ) were used in PCR techniques to amplify the homologous region of
the elasmobranch electric fish (Discopyge ommata) neurexin
from an EMN gt10 cDNA library (a gift from K. Buckley, Harvard
University, Cambridge, MA) (Trimble et al., 1988 ) with a Perkin-Elmer
(Norwalk, CT) 9600 thermocycler based on described methods (Sambrook et al., 1989 ). We used the following primers in the PCR methods: sense
primer, GAGAGAGAATTCCTNTAYGCNATGTAYAARTA; antisense primer, GAGAGAGCGGCCGCTTANACRTARTAYTCYTTRTCYTT (N = A, T, G, and C; Y = C and T; and R = A and G). DNA sequencing was performed using a
Sequenase autoradiographic sequencing kit (Amersham, Cleveland, OH) and
a sequencing gel apparatus (Bio-Rad, Hercules, CA). Analyses of DNA
sequences were performed with a UNIX-based software package (Wisconsin
Package, Genetics Computer Group, Madison, WI). The amplified fragment
was subcloned into a glutathione S-transferase (GST)
expression vector (pGEX-5X, Pharmacia, Piscataway, NJ), and the fusion
vector was sequenced to verify that the fragment was inserted
correctly. The GST-electric fish neurexin fusion protein
(GST-neurexin) was expressed at high levels in bacteria and purified
according to the suggestions of the manufacturer (Pharmacia). A second
expression vector was constructed using the same electric fish neurexin
fragment and the maltose-binding protein (MBP) vector (New England
Labs, Cambridge, MA). The MBP-electric fish neurexin fusion protein
(MBP-neurexin) was expressed in bacteria and purified according to the
suggestions of the manufacturer.
Anti-electric fish neurexin antibody production and
purification. Rabbits were immunized with purified GST-neurexin
fusion protein according to described methods (Harlow and Lane, 1988 ). The resulting anti-neurexin antibodies were affinity purified using the
GST-neurexin fusion protein covalently linked to
glutathione-Sepharose resin using dimethylpimelimidate (DMP) as the
cross-linking reagent (GST-neurexin resin) (Brew et al., 1975 ). To
accomplish this, the fusion protein was first bound to
glutathione-Sepharose resin, and the resin was exposed to 100 mM DMP, pH 8.2, overnight at 4°C. After this reaction was
complete, the resin was washed repeatedly with 0.2 M HEPES,
pH 8.2, and then once with 20 mM ethanolamine to quench any
remaining cross-linking reagent. We washed the resin with 100 mM 3-(cyclohexylamino)-1-propanesulfonic acid, pH 11.5, to
remove any bound proteins that had not been cross-linked. The fusion
protein resin was neutralized with 100 mM NaCl and 50 mM 4-morpholinepropanesulfonic acid, pH 6.8.
Specificity of the antibodies was demonstrated by adsorbing the
affinity-purified antibodies with GST-neurexin resin in 5% bovine
serum albumin and testing the adsorption on Western blots of
MBP-neurexin. As a control for the adsorption, a GST fusion protein
containing a region of the rat potassium channel (a gift from B. Tempel, University of Washington) (Wang et al., 1993 ) was cross-linked
to glutathione-Sepharose resin (GST-K+ resin) with
100 mM DMP. Specific anti-neurexin antibodies were identified as those antibodies blocked by GST-neurexin resin but not
by GST-K+ resin. All Western blots and
immunocytochemical experiments were performed with affinity-purified
anti-electric fish neurexin antibodies that had been adsorbed with
GST-K+ resin to remove anti-GST antibodies.
Immunocytochemistry. Marine elasmobranch electric rays,
Torpedo californica (Marinus) or Narcine
brasiliensis (Gulf Specimens), were anesthetized as described
previously (Carlson et al., 1978 ). The electric organ, EMN, and
electromotor nerve were dissected (See Fig. 1 for
schematic representation of the electric fish tissues used in this
study) and immersion-fixed in 4% paraformaldehyde. After
cryoprotection, 25 µm sections were cut with a cryostat (Reichert-Jung). In some cases, sections were incubated in methanol to
aid in antibody penetration into the tissue (Hockfield et al., 1993 ).
Sections were labeled with primary antibodies, and bound antibodies
were detected using fluorescent secondary antibodies (Jackson
Immunochemicals, West Grove, PA) following described methods (Hockfield
et al., 1993 ). Labeled sections were analyzed on a fluorescent confocal
microscope (Bio-Rad), and images were collected using an IBM PC
computer.
Fig. 1.
Schematic diagram of the electromotor pathway.
Electromotor neurons originate in the EMN and send out processes that
synapse on the electrocytes of the electric organ. The collection of
axonal processes constitutes the electromotor nerve (EM
Nerve). A single electromotor neuron (EM Neuron)
is shown as an example of the locations of the neuronal cell body,
axonal process, and nerve terminal. The EMN, electromotor nerve, and
electric organ tissues were extracted from T.
californica and N. brasiliensis for this study.
All marine elasmobranch electric rays share this electromotor pathway.
SC, Spinal cord; CE, cerebellum;
OpT, optic tectum; Olf, olfactory lobes.
Modified from Bennet (1971) . The drawing is for illustrative purposes,
and the relative size of the electromotor neuron is not accurate. Only
one of the two electric organs is shown for the sake of
simplicity.
[View Larger Version of this Image (28K GIF file)]
Tissue extractions. The EMN, electromotor nerve, and
electric organ were removed from an anesthetized fish as described
previously (Carlson et al., 1978 ). The EMN contains primarily the cell
bodies of the electromotor neurons; the electromotor nerve contains the axons of the electromotor neurons; and the electric organ contains the
axons and nerve terminals of these neurons (see Fig. 1). The EMN and
electromotor nerve were extracted once with 280 mM NaCl, 10 mM Tris-Cl, pH 7.5 (5× volume per weight of tissue), and
protease inhibitors (1 mM diisopropylfluorophosphate,
100 µM pepstatin, 100 µM leupeptin, and 100 µM chyhmostatin). After a 10,000 × g centrifugation for 30 min, the pellets were extracted for 2 hr with 3%
Triton X-100, 280 mM NaCl, 10 mM Tris-Cl, pH
7.5 (5× volume per weight of original tissue), and protease inhibitors
and then centrifuged at 20,000 × g for 10 min. The
resulting detergent-resistant pellets were extracted for 2 hr with 8 M urea, 0.5% Triton X-100, 280 mM NaCl, 10 mM Tris-Cl, pH 7.5 (5× volume per weight of original tissue), and protease inhibitors and centrifuged at 20,000 × g for 10 min to produce a supernatant. The electric organ
was treated according to the method of Godfrey et al. (1984) to prepare
an insoluble fraction that is enriched in ECM proteins. This
preparation yields an initial salt extract (400 mM NaCl, 1 mM EGTA, 1 mM EDTA, and 10 mM
Tris-Cl, pH 7.5) of the electric organ and a detergent extract (3%
Triton X-100 and 10 mM Tris-Cl, pH 7.5) of the
salt-resistant pellet. The detergent-resistant pellet was washed with a
series of salt buffers (400 to 100 mM NaCl
buffered with Tris-Cl, pH 7.5) before urea extraction (8 M
urea, 0.5% Triton X-100, and 10 mM Tris-Cl, pH 7.5).
Miscellaneous procedures and reagents. SDS-PAGE and
immunoblotting techniques were performed as described (Hockfield et
al., 1993 ). Anti-SV2 monoclonal antibody supernatants (Buckley and Kelly, 1985 ) were prepared as described (Hockfield et al., 1993 ). Anti-tubulin antibodies were a kind gift from Dr. L. Wordeman (University of Washington). Anti-maltose-binding protein antibodies were provided by New England Labs, and anti-myelin basic protein antibodies were from Chemicon (Temecula, CA)
RESULTS
Generation of specific anti-electric fish
neurexin antibodies
To generate antibodies most likely to cross-react with all
potential neurexin forms expressed by the EMN neurons that innervate the electric organ, we created a fusion protein containing the intracellular domain of electric fish neurexin to immunize rabbits. The
intracellular domain is the most highly conserved region among the
known neurexins from rat and cow (Ushkaryov et al., 1992 , 1994 ;
Ushkaryov and Südhof, 1993 ). Antibodies made by other
investigators to this domain of rat neurexins recognize all - and
-forms derived from the three neurexin genes, except the alternative
splice variant of rat neurexin II that results in a unique C terminus
(Ushkaryov et al., 1992 ). To construct this fusion protein for electric
fish neurexins, we first isolated an electric fish cDNA fragment
encoding this neurexin domain using degenerate primers based on the
highly conserved intracellular sequences of rat and cow neurexins
(Ushkaryov et al., 1992 , 1994 ; Ushkaryov and Südhof, 1993 ) and
PCR methods. These procedures allowed us to amplify this cDNA from a
D. ommata elasmobranch electric ray EMN gt10 cDNA
library. Analysis of the amino acid sequence deduced from the isolated
electric fish neurexin cDNA fragment indicated high homology with all
of the neurexins from cow and rat, excluding the unique splice variant of neurexin II, with the highest homology of EMN neurexin with rat
neurexin III . EMN neurexin shares 79.7% identity with rat neurexin
III (Fig. 2A), 79.3% identity with rat neurexin I , and 76.3% identity with rat neurexin II . The cDNA fragment encoding the entire intracellular domain of electric fish neurexin was subcloned
into a GST expression vector, and both strands of the vector were
sequenced to verify that the fragment was inserted in the correct
orientation and reading frame. After expression in bacteria, the
purified fusion protein (GST-neurexin) was used to immunize
rabbits.
Fig. 2.
Generation of specific anti-electric fish neurexin
antibodies. A, Amino acid sequence alignment of electric
fish neurexin to rat neurexin III . The amino acid sequence for
electric fish neurexin was deduced from an isolated electric fish
neurexin cDNA fragment. cDNA encoding the entire cytosolic domain from
the end of the transmembrane region to the C terminus of electric fish neurexin was isolated using PCR amplification from a D.
ommata elasmobranch electric ray EMN gt10 cDNA library. With
this cDNA fragment, we constructed a GST-neurexin fusion vector, and
the resulting purified fusion protein was used to produce antisera in
rabbits. Solid lines denote identical amino acids;
colons denote conserved amino acid changes. The electric
fish neurexin fragment (EMN) is 79% identical to
rat neurexin III (RAT). B,
Specificity of the anti-neurexin antibodies. We constructed a second
fusion protein, a maltose-binding protein-neurexin with the same
cytosolic domain of electric fish neurexin, and subjected the purified
protein to SDS-PAGE and immunoblotting procedures. The blotted fusion protein was probed with anti-maltose-binding protein
(anti-MBP) antibodies, resulting in a band of the
expected molecular mass of 45 kDa (denoted by
asterisks). The arrowhead most likely
represents a proteolytic cleavage fragment of MBP-neurexin.
MBP-neurexin was also probed with affinity-purified anti-electric fish
neurexin (anti-NRX) antibodies incubated with a
GST-K+ fusion protein covalently attached to
glutathione-Sepharose resin (GST-K+
Incub.) (See Materials and Methods) or with
GST-neurexin similarly attached to glutathione-Sepharose resin
(GST-NRX Incub.). For the rest of the study and
subsequent experiments, anti-electric fish neurexin antibodies were
affinity-purified on GST-neurexin resin, followed with adsorption with
GST-K+ resin to remove antibodies to GST proteins.
Numbers on the left represent molecular
masses in kilodaltons.
[View Larger Version of this Image (39K GIF file)]
To affinity purify anti-electric fish neurexin antibodies,
GST-neurexin was bound to glutathione-Sepharose beads and then incubated with 100 mM DMP to cross-link the fusion protein
covalently to the resin. After cross-linking of the fusion protein to
the glutathione-Sepharose resin, we passed rabbit antisera over the resin, and bound antibodies were eluted by an alkaline pH.
Verifying the specificity of anti-electric fish
neurexin antibodies
To be certain that the affinity-purified anti-electric fish
neurexin antibodies were specific to the intracellular fragment of
electric fish neurexin, we used a second fusion protein to assay the
antibodies. The second fusion protein contained MBP and the same
intracellular fragment of electric fish neurexin used to construct
GST-neurexin. The second fusion protein (MBP-neurexin) should be
recognized only by antibodies to the intracellular fragment of electric
fish neurexin and not by anti-GST antibodies. Western blot analysis of
purified MBP-neurexin with anti-maltose-binding protein antibodies
resulted in a band of the expected molecular weight of 45 kDa for the
fusion protein (Fig. 2B, asterisk). A small amount of the fusion protein seemed to be partially proteolyzed (Fig. 2B, arrowhead). The anti-electric fish neurexin
antibodies were incubated either with GST-neurexin (GST-NRX)
covalently attached to glutathione-Sepharose or with a GST-potassium
channel (GST-K+) fusion protein similarly attached
to glutathione-Sepharose. After incubation with the resins, we used
the antibodies to probe MBP-neurexin. We find that exposure of the
antibodies with GST-K+ resin does not block their
binding to MBP-neurexin, but incubation with GST-neurexin resin
abolishes immunoreactivity (Fig. 2B). Clearly, our
anti-electric fish neurexin antibodies contain immunoreactivity to the
C-terminal domain of neurexin, because this immunoreactivity is
unaffected by exposure to the GST carrier protein. For all of the
experiments reported in this study, anti-electric fish neurexin
antibodies were first affinity-purified on GST-neurexin resin and then
adsorbed with GST-K+ resin.
A 140 kDa form of neurexin is common to EMN, electromotor nerve,
and electric organ tissues
To gain an understanding of how many potential forms are expressed
by the neurons innervating the electric organ, we extracted neurexins
from the elasmobranch EMN, electromotor nerve, and electric organ. The
EMN contains the cell bodies and axons of the electromotor neurons, the
electromotor nerve contains primarily the axons of the electromotor
neurons, and the electric organ contains the axons and nerve terminals
of these neurons (Fig. 1). If the electromotor neurons are producing a
neurexin and transporting it to the electric organ, it should be found
in all three tissues. Salt, detergent, and urea extracts were prepared
from the tissues, separated by SDS-PAGE, and analyzed by Western blot
using antibodies to electric fish neurexin. Salt extraction is expected
to solubilize cytosolic proteins, detergent extraction to solubilize
membrane-associated proteins, and urea extraction to solubilize
extracellular matrix and cytoskeletal proteins in addition to membrane
proteins tightly associated with these proteins (Hockfield et al.,
1993 ). We surveyed all of the extracts by Western blotting and found
immunoreactive proteins only in detergent and urea extracts (Fig.
3). These proteins have molecular weights expected for
-neurexins (45-66 kDa) and -neurexins (150-210 kDa) (Ushkaryov
et al., 1992 , 1994 ; Ushkaryov and Südhof, 1993 ).
Fig. 3.
Extraction of neurexins from elasmobranch EMN,
electric organ, and electromotor nerve. The electric organ
(EO) was extracted according to the method of Godfrey et
al. (1984) , resulting in an initial buffered 400 mM NaCl
salt extract of the electric organ (lane A), 3% Triton
X-100 detergent extract of the electric organ (lane B),
and an 8 M urea extract of the ECM-rich fraction (See Materials and Methods) (lane C). The EMN and
electromotor nerve tissues were extracted with buffered 250 mM NaCl salt solution (lanes D,
G), and the resulting pellet was extracted with buffered 3% Triton X-100 (lanes E, H, J). The
detergent-resistant material was extracted with buffered 8 M urea (lanes F, I, K). Extracts were
separated by SDS-PAGE, immunoblotted, and probed with anti-electric fish neurexin antibodies. A 140 kDa form of neurexin is found to be
common to all three tissues (arrowheads) as well as
forms of neurexin specific to the tissue source
(asterisks). The doublet in lane I may
represent neurexin that has not been completely processed by the
biosynthetic pathway in the EMN. For lanes A-I, the
anti-electric fish neurexin antibodies were incubated with GST-K+ resin to remove antibodies to GST. To
demonstrate specificity, the EMN extracts were probed with
anti-electric fish neurexin antibodies incubated with GST-neurexin
resin (lanes J, K). Numbers on the
left represent molecular masses in kilodaltons.
[View Larger Version of this Image (46K GIF file)]
We discovered that a form of neurexin with a molecular weight of 140 kDa is common to EMN, electromotor nerve, and electric organ tissues
(Fig. 3, lanes C, F, I, arrowheads). This localization suggests that the 140 kDa neurexin is the product of the electromotor neurons. This protein requires urea for extraction. The apparent doublet observed in the EMN extract may represent neurexin that has
undergone alternative splicing or neurexin that has not been completely
processed in the biosynthetic pathway (Fig. 3, lane I). In addition to the 140 kDa form of neurexin, we find
neurexins specific to each tissue as well (Fig. 3,
asterisks). As a test for the specificity of the
anti-electric fish neurexin antibodies and to confirm that the proteins
observed are attributable to specific antibody reactivity, we probed a
blot of the detergent and urea extracts from the EMN with anti-electric
fish neurexin antibodies incubated with GST-neurexin resin (Fig. 3,
lanes J and K). The results show no
reactivity, agreeing with our results with MBP-neurexin and confirming
specificity of the antibodies. The observed molecular weight of 140 kDa
is in agreement with the expected molecular weight for an -neurexin
(150-205 kDa) based on published data (Ushkaryov et al., 1992 , 1994 ;
Ushkaryov and Südhof, 1993 ).
The 66 and 210 kDa forms of neurexin
In addition to the 140 kDa form of neurexin, which is common to
the EMN, electromotor nerve, and electric organ, we found another form
in the EMN and electromotor nerve and a third form in the electric
organ. We observed a 210 kDa form of neurexin in the electric organ
that requires urea for extraction (Fig. 3, lane C,
asterisk). Both the nerve and the EMN express a 66 kDa form of
neurexin that requires nondenaturing detergent for extraction, and in
the case of the EMN, the 66 kDa form is also extracted with urea (Fig.
3, lanes E, H, and I, asterisks). A molecular
weight of 210 kDa is consistent with an -neurexin (150-205 kDa),
and 66 kDa is consistent with a -neurexin (45-66 kDa) (Ushkaryov et
al., 1992 , 1994 ; Ushkaryov and Südhof, 1993 ).
Neurexin is expressed by neurons in the EMN
To verify that electromotor neurons are making a neurexin, we
stained cryostat sections of the EMN with our anti-electric fish
neurexin antibodies. We find that neurexin immunoreactivity is
localized in the perinuclear region of the EMN neurons (Fig. 4A, arrow), consistent with
a Golgi localization and strongly suggesting that these cells are
making neurexin. EMN sections labeled with antibodies to the synaptic
vesicle protein SV2 demonstrated a similar perinuclear expression
pattern (Fig. 4B, arrow). Labeling of EMN sections
with antibodies to myelin basic protein, which is made exclusively by
glial cells, resulted in immunoreactivity on fibers within the EMN
(Fig. 4D, arrowhead) but no cytoplasmic staining
within the neuronal cell (Fig. 4D, arrow). As a test for specificity, the anti-electric fish neurexin antibodies were incubated with GST-neurexin resin, resulting in essentially a complete
block of antibody binding (Fig. 4C).
Fig. 4.
Perinuclear expression of neurexin in EMN neurons.
Sections of EMN from elasmobranch were labeled with antibodies to
electric fish neurexin (A), the synaptic vesicle
protein SV2 (B), myelin basic protein
(D), and anti-electric fish neurexin antibodies exposed to GST-neurexin resin (C). Neurexin is
expressed in the perinuclear region in EMN neurons (A,
arrow) in a manner similar to SV2 (B, arrow).
The perinuclear staining pattern is consistent with Golgi localization,
suggesting that the neuronal cell bodies are producing neurexin. Myelin
basic protein is not expressed by EMN neurons (D, arrow)
but is expressed on fibers (D, arrowhead). Incubation of
electric fish neurexin antibodies with GST-neurexin resin results in
the block of perinuclear immunoreactivity (C, arrow).
Sections were counterstained with methylene green. Scale bar in
C, 50 µm.
[View Larger Version of this Image (138K GIF file)]
Neurexin is not expressed at nerve terminals but is expressed on
nerve fibers
From the neurexin hypothesis, we would expect neurexin to be
localized to nerve terminals of electromotor neurons. As a test of the
hypothesis, we double-labeled electric organ sections with antibodies
to SV2, a synaptic vesicle protein (Buckley and Kelly, 1985 ), to label
nerve terminals and antibodies to electric fish neurexin (Fig.
5A-C). Contrary to expectations, our results
show that neurexin is not detected at nerve terminals but is expressed on nerve fibers. Antibodies to SV2 labeled nerve terminals (Fig. 5A,C, asterisks) and axons as well (Fig. 5A,C,
arrows). The nerve terminals completely cover the ventral surfaces
of the electrocytes (Bennet, 1971 ). Anti-neurexin antibodies show
strong immunoreactivity on nerve fibers (Fig. 5B, arrow) and
perineurial cells (Fig. 5B, arrowhead) but no staining at
nerve terminals in the same section (Fig. 5B, asterisk). We
did not observe any overlap of the SV2 and neurexin immunoreactive
signals on nerve terminals (Fig. 5C).
Fig. 5.
Neurexin is not expressed at nerve terminals, but
is expressed on nerves. An electric organ section was double-labeled
with a monoclonal antibody to the synaptic vesicle protein SV2
(A) and anti-electric fish neurexin
(B). Sections were also labeled with antibodies
to myelin basic protein (D, G) and anti-electric fish
neurexin (E, H). Images were merged to determine
the relative positions of the signals (C, F, I).
Bound antibodies were detected with fluorescein anti-mouse
(A) or fluorescein anti-rat (D, G) and rhodamine anti-rabbit (B, E, H) antibodies
and viewed on a confocal microscope. Neurexin is absent from nerve
terminals (A, B, asterisks), as labeled by SV2, but is
found on nerve fibers (B, arrows) and perineurial cells
(B, arrowhead). SV2 immunoreactivity labels nerve
terminals that completely cover the ventral surfaces of the electrocyte
(B, asterisk). Myelin basic protein immunoreactivity is
localized to nerve fibers (D, arrow). Neurexin is
localized to the nerve fibers (E, arrow) and perineurial
cells (E, arrowhead). Neurexin immunoreactivity on nerve
fibers overlaps with myelin basic protein immunoreactivity
(F). In H, anti-electric
fish neurexin antibodies were preincubated with GST-neurexin resin
before application to the section. Scale bars: A, 100 µm; D, G, 25 µm.
[View Larger Version of this Image (100K GIF file)]
In an attempt to determine more precisely where neurexin is expressed
in the nerve fiber, we double-labeled electric organ sections with
antibodies to myelin basic protein and to electric fish neurexin (Fig.
5D-I). Myelin basic protein immunoreactivity is localized to the nerve fiber in the electric organ (Fig. 5D,G, arrows). Immunoreactivity for neurexin is also localized to the nerve fiber in the electric organ (Fig. 5E, arrow) as well
as to perineurial cells (Fig. 5E, arrowhead). We observe
that neurexin immunoreactivity overlaps with myelin basic protein
immunoreactivity on the nerve fibers in the electric organ (Fig.
5F, arrow). Incubation of the anti-electric fish neurexin
antibodies with GST-neurexin resin resulted in a complete block of
immunoreactivity (Fig. 5H), with no overlapping
signal with myelin basic protein immunoreactivity (Fig.
5I), verifying the specificity of the antibody
reaction.
The apparent overlap of neurexin immunoreactivity with myelin basic
protein immunoreactivity was examined in greater detail by looking at
longitudinal sections of the electromotor nerve. We double-labeled
longitudinal sections of the electromotor nerve with antibodies to
electric fish neurexin and myelin basic protein (Fig.
6). We find the immunoreactive signals not to overlap
completely, as should be expected if the axons are expressing neurexin
in the nerve fiber (Fig. 6, arrows). When we look more
closely at the nerve sections, we find that the signals are separate,
with neurexin immunoreactivity interior to myelin basic protein
immunoreactivity (Fig. 6D-F, arrows). Because the
neurons of the electromotor nerve are producing neurexin (Fig.
4A), and we do not observe neurexin immunoreactivity
at nerve terminals, we propose that the EMN neurons produce neurexin
destined for axonal membrane localization.
Fig. 6.
Partial overlap of neurexin and myelin basic
protein immunoreactivity on electromotor nerve. Longitudinal sections
of electromotor nerve were double-labeled with anti-myelin basic
protein (A, D) and anti-electric fish neurexin
(B, E) antibodies. Images were merged to determine the
relative positions of the signals (C, F). Both
antigens are localized to the edge of the nerve fibers (arrows). The neurexin signal is localized interior to
the myelin basic protein signal (D-F, arrows). As a
reference point, the asterisks in D-F
mark the axoplasm of the nerve fiber. Myelin basic protein and neurexin
seem to overlap partially, presumably because the resolution of the
myelin sheath and axonal membrane are near the limit of resolution of
the confocal microscope. Scale bars in B and
D, 25 µm.
[View Larger Version of this Image (66K GIF file)]
Perineurial cells express neurexin
In nerves, axon bundles are ensheathed by concentric layers of
thin fibroblast-like cells, which constitute the perineurium (Thomas,
1963 ). These perineurial cells of the electromotor nerves contain
neurexin. This is apparent in sections of electric organ double-labeled
with antibodies to tubulin and electric fish neurexin (Fig.
7). The anti-tubulin antibodies stain not only the axons (Fig. 7A,C, arrowheads) but also the thin layers of
fibroblastic cells of the perineurium (Fig. 7A,C, arrows)
(Burkel, 1967 ). These layers of perineurial cells also stain for
neurexin immunoreactivity (Fig. 7B,D, arrows). We noticed
that detection of neurexin immunoreactivity on the axon was strongest
when methanol was used during the tissue section preparation (Fig.
7D). When methanol was excluded, neurexin immunoreactivity
was weaker in the axon (Fig. 7B). This most likely represents a difference in the ability of the anti-neurexin antibodies to penetrate the tissue.
Fig. 7.
Colocalization of neurexin with tubulin in the
perineurium. Electric organ sections were double-labeled with
anti-tubulin (A, C) and anti-electric fish neurexin
(B, D) antibodies. Both antigens are found in axons
(arrowheads) and perineurial cells (arrows). The section in C and
D was treated with methanol to increase the signal
observed in axons (arrowheads). Methanol treatment presumably increases antibody penetration into the axon. Scale bar in
C, 25 µm.
[View Larger Version of this Image (149K GIF file)]
DISCUSSION
Neurexins are polymorphic transmembrane proteins presumed to be
involved in synaptic neuron-neuron interactions. Neurexin is
hypothesized to be restricted to the nerve terminal because of the
ability of the intracellular domain to bind the synaptic vesicle
protein synaptotagmin and the immunolocalization to nerve terminals in
the rat CNS (Geppert et al., 1992 ; Ushkaryov et al., 1992 ; Hata et al.,
1993 ). The extensive variability of the extracellular domain of
neurexin is predicted to confer postsynaptic ligand specificity that
reflects the synaptic complexity of the CNS. The electric organ from
the marine elasmobranch electric ray provides a model to test the
hypothesis. The hypothesis would predict that a small complement of
neurexin forms would be restricted to the nerve terminal in the
electric organ. In contrast, we find that neurexin is not present at
nerve terminals. Instead, neurexin is expressed on nerve fibers as well
as non-neuronal perineurial cells. We obtained this result with
antibodies to the homologous region of fish neurexin, much as previous
workers used them in experiments to propose the neurexin hypothesis
(Geppert et al., 1992 ; Ushkaryov et al., 1992 ). We find a 140 kDa form
of neurexin common to the EMN, electromotor nerve, and electric organ,
which is presumably expressed on the axons of the EMN cells, which are the only cells common in these three tissues. We also find forms of
neurexin that are non-neuronal in origin. Thus, our observations do not
support the neurexin hypothesis.
Although neurexins may be nerve terminal proteins in the CNS,
their absence at electric organ synapses argues against a universal role for neurexin as a nerve terminal protein. Neurexins containing the
C terminus that our antibodies recognize have been detected at CNS
nerve terminals, but these variants are not present at peripheral
electric organ nerve terminals. Instead, we have detected neurexins on
axons and perineurial cells. However, it cannot be ruled out that
neurexin variants with unique C termini that our antibodies are unable
to recognize are present at the electric organ synapse. The status of
neurexin as a functional component of the exocytotic machinery may have
to be reconsidered in light of new evidence. Neurexin was originally
isolated as the nerve terminal receptor for -latrotoxin, which
causes massive exocytosis (Gorio et al., 1978 ; Ushkaryov et al., 1992 ).
However, recent studies have reported the isolation of a
calcium-independent -latrotoxin receptor that is biochemically
distinct from the neurexins (Davletov et al., 1996 ; Krasnoperov et al.,
1996 ).
Our data suggest that electromotor neurons express an -neurexin but
localize it in membranes adjacent to myelin enwrapments of Schwann
cells. The evidence is the following: (1) The electromotor neurons seem
to be synthesizing a neurexin. Immunocytochemical data show a
perinuclear neurexin immunoreactivity in the cell bodies of the
electromotor neurons. This localization strongly suggests the presence
of neurexin in the Golgi apparatus, which is part of the biosynthetic
machinery for plasma membrane proteins and secreted glycoproteins
(Alberts et al., 1994 ). This staining pattern is exactly like that of
the synaptic vesicle protein SV2, a known product of electromotor
neurons (Scranton et al., 1993 ; Buckley and Kelly, 1985 ). (2)
Immunocytochemical localization shows neurexin immunoreactivity on
axonal membranes, adjacent to the myelin sheath. (3) The tissues that
contain the electromotor neurons and their processes, the EMN, the
electromotor nerves, and electric organ, also contain the 140 kDa
neurexin. These are the major neurons of the EMN and probably the only
neurons that the electromotor nerve and electric organ contain (Bennet,
1971 ). A molecular mass of 140 kDa is within the range expected for an -neurexin (Ushkaryov et al., 1992 ; Ushkaryov and Südhof, 1993 ; Ushkaryov et al., 1994 ).
In addition to the 140 kDa neurexin, which is common to all tissues of
the electromotor pathway, we found two other neurexins: 210 and 66 kDa
proteins, most likely - and -neurexins, respectively. We found
the 210 kDa protein in the electric organ and the 66 kDa protein in the
electromotor nerve, which is located outside of the electric organ, and
in the EMN. The origins of these neurexins are unclear, but they are
presumably produced by cells other than the electromotor neurons. The
210 kDa protein may be the neurexin produced by the perineurial cells
in the nerves inside the electric organ, whereas the 66 kDa neurexin
may be made by perineurial cells in the electromotor nerve outside of
the electric organ. Perhaps this difference in neurexins might reflect
the two different environments of the perineurial cells in the
electromotor nerve, especially if neurexin is involved in cell-cell or
cell-matrix interactions. Outside the electric organ, the perineurial
cells form a layer around the entire nerve bundle. Inside the electric organ, these cells interdigitate into the nerve surrounding bundles of
myelinated axons, dividing the nerve into separate cables. This occurs
before branch points in the nerve (Terzis and Smith, 1990 ), and the
electromotor nerve only branches inside the electric organ.
We hypothesize a role for neurexin as a cell adhesion protein involved
in the formation and maintenance of tight cellular interactions
associated with the peripheral nerve and axon bundles. We find neurexin
immunoreactivity at the axon-Schwann cell boundary and on perineurial
cells that ensheath the nerve. The interaction between perineurial
cells and the interaction between axons and Schwann cells share many
similarities. The two types of interactions involve a close
juxtaposition of membranes to act as a diffusion barrier. Results from
electron microscopy studies examining the association of the membranes
of the Schwann cell and axon resemble perineurial cell junctions
(Burkel, 1967 ; Little et al., 1995 ). The Schwann cell forms a barrier
around the axon by the tight association of the myelin sheath (Terzis
and Smith, 1990 ). The barrier provided by the tight association of the
myelin sheath acts to increase the membrane resistance and to decrease
the capacitance associated with the axon (Hille, 1992 ). The perineurial
cells are arranged in concentric layers to form a metabolic diffusion barrier (Burkel, 1967 ) and to protect the axon from infectious agents
(Terzis and Smith, 1990 ).
Work in Drosophila also suggests that neurexins are involved
in the formation of tight cellular junctions. Neurexin has been reported to be involved in septate junction formation in
Drosophila (Baumgartner et al., 1996 ). Septate junctions are
formed between glial cells to form a blood-brain barrier around nerves
in invertebrates and serve a similar function to that of perineurial
cells in vertebrates. Septate junctions fail to form in
Drosophila mutants that lack neurexin, resulting in a
breakdown of the blood-brain barrier (Baumgartner et al., 1996 ). It
seems that neurexin in the peripheral nerve is involved in the
formation of cell-cell interactions that are required for forming
specialized barriers.
In this study, we sought to test the neurexin hypothesis that neurexin
is localized solely at nerve terminals in the elasmobranch electric
organ. Our observations argue against a universal role for neurexins as
nerve terminal-specific proteins and suggest a different role for
neurexins in the periphery. Our findings suggest that neurexin in the
electric organ, rather than being involved in synaptic connectivity,
may be involved in perineurial cell adhesion and axon-Schwann cell
interactions. Future studies will examine the role of neurexin in
axon-Schwann cell interactions during peripheral nerve
development.
FOOTNOTES
Received March 3, 1997; revised April 1, 1997; accepted April 9, 1997.
This work was supported by the W. M. Keck Foundation, National
Institutes of Health Grant NS 22367, and a NASA Graduate Student Research Program Fellowship (A.B.R.). We thank Lorraine Gibbs for
technical assistance with immunocytochemistry experiments and Paulette
Bruenner at the W. M. Keck Center for Advanced Studies in Neural
Signaling for assistance with confocal microscopy, Kathy Buckley for
the D. ommata EMN gt10 cDNA library, Linda Wordeman for anti-tubulin antibodies, and Bruce Tempel for the GST-potassium channel fusion protein. We also thank Regis Kelly and Mani Ramaswami for assistance in the initiation of this study, Laura Ginkel, Andy
Hunter, and Tom Knight for useful discussions, and Linda Wordeman for
critical evaluation of this manuscript.
The GenBank accession number for the EMN neurexin cDNA fragment used to
construct the pGEX expression vector is U95949[GenBank].
Parts of this paper were reported previously at the 22nd Society of
Neuroscience Meeting, Washington, DC, 1996.
Correspondence should be addressed to Dr. Steven. S. Carlson,
Department of Physiology and Biophysics, Mail Code 357290, University of Washington, Seattle, WA 98195.
REFERENCES
-
Alberts B,
Bray D,
Lewis J,
Raff M,
Roberts K,
Watson JD
(1994)
In: Molecular biology of the cell. New York: Garland.
-
Baumgartner S,
Littleton JT,
Broadie K,
Bhat MA,
Harbecke R,
Lengyel JA,
Chiquet-Ehrismann R,
Prokop A,
Bellen HJ
(1996)
A Drosophila neurexin is required for septate junction and blood-nerve barrier formation and function.
Cell
87:1059-1068[Web of Science][Medline].
-
Bennet MVL
(1971)
Electric organs.
In: Fish physiology (Hoar WS,
Randall DJ,
eds), pp 347-491. New York: Academic.
-
Brew K,
Shaper JH,
Olsen KW,
Trayer IP,
Hill RL
(1975)
Cross-linking of the components of lactose synthetase with dimethylpimelimidate.
J Biol Chem
250:1434-1444[Abstract/Free Full Text].
-
Buckley K,
Kelly RB
(1985)
Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells.
J Cell Biol
100:1284-1294[Abstract/Free Full Text].
-
Burkel WE
(1967)
The histological fine structure of perineurium.
Anat Rec
158:177-190[Medline].
-
Carlson SS,
Wagner JA,
Kelly RB
(1978)
Purification of synaptic vesicles from elasmobranch electric organ and the use of biophysical criteria to demonstrate purity.
Biochemistry
17:1188-1199[Medline].
-
Davletov BA,
Shamotienko OG,
Lelianova VG,
Grishin EV,
Ushkaryov YA
(1996)
Isolation and biochemical characterization of a Ca2+-independent
-latrotoxin-binding protein.
J Biol Chem
271:23239-23245[Abstract/Free Full Text]. -
Geppert M,
Ushkaryov YA,
Hata Y,
Davletov B,
Petrenko AG,
Südhof TC
(1992)
Neurexins.
Cold Spring Harb Symp Quant Biol
57:483-490[Abstract/Free Full Text].
-
Godfrey EW,
Nitkin RM,
Wallace BG,
Rubin LL,
McMahan UJ
(1984)
Components of Torpedo electric organ and muscle that cause aggregation of acetylcholine receptors on cultured muscle cells.
J Cell Biol
99:615-627[Abstract/Free Full Text].
-
Gorio A,
Rubin LL,
Mauro A
(1978)
Double mode of action of black widow spider venom on frog neuromuscular junction.
J Neurocytol
7:193-205[Web of Science][Medline].
-
Harlow E,
Lane D
(1988)
In: Antibodies: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor.
-
Hata Y,
Davletov B,
Petrenko AG,
Jahn R,
Südhof TC
(1993)
Interaction of synaptotagmin with the cytoplasmic domains of neurexins.
Neuron
10:307-315[Web of Science][Medline].
-
Hille B
(1992)
In: Ionic channels of excitable membranes. Sunderland, MA: Sinauer.
-
Hockfield S,
Carlson S,
Evans C,
Levitt P,
Pintar J,
Silberstein L
(1993)
In: Selected methods for antibody and nucleic acid probes. Cold Spring Harbor, NY: Cold Spring Harbor.
-
Krasnoperov VG,
Beavis R,
Chepurny OG,
Little AR,
Plotnikov AN,
Petrenko AG
(1996)
The calcium-independent receptor of
-latrotoxin is not a neurexin.
Biochem Biophys Res Commun
227:868-875[Web of Science][Medline]. -
Little GJ,
Robinson CS,
Heath JW
(1995)
Cryo-immunogold ultrastructure localization of laminin in adult rat peripheral nerve.
J Neurocytol
24:79-84[Web of Science][Medline].
-
O'Connor VM,
Shamotienko O,
Grishin E,
Betz H
(1993)
On the structure of the "synaptosecretosome." Evidence for a neurexin/synaptotagmin/syntaxin/Ca2+ channel complex.
FEBS Lett
326:255-260[Web of Science][Medline].
-
Perin MS
(1994)
The COOH terminus of synaptotagmin mediates interaction with the neurexins.
J Biol Chem
269:8576-8581[Abstract/Free Full Text].
-
Petrenko AG
(1993)
-Latrotoxin receptor. Implications in nerve terminal function.
FEBS Lett
325:81-85[Web of Science][Medline]. -
Petrenko AG,
Perin MS,
Davletov BA,
Ushkaryov YA,
Geppert M,
Südhof TC
(1991)
Binding of synaptotagmin to the
-latrotoxin receptor implicates both in synaptic vesicle exocytosis.
Nature
353:65-68[Medline]. -
Sambrook J,
Fritsch EF,
Maniatis T
(1989)
In: Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor.
-
Scranton TW,
Iwata M,
Carlson SS
(1993)
The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan.
J Neurochem
61:29-44[Web of Science][Medline].
-
Terzis JK,
Smith KL
(1990)
In: The peripheral nerve: structure, function, and reconstruction. New York: Raven.
-
Thomas PK
(1963)
The connective tissue of peripheral nerve: an electron microscope study.
J Anat
97:35-44[Web of Science][Medline].
-
Trimble WS,
Cowan DM,
Scheller RH
(1988)
VAMP-1: a synaptic vesicle-associated integral membrane protein.
Proc Natl Acad Sci USA
85:4538-4542[Abstract/Free Full Text].
-
Ushkaryov YA,
Südhof TC
(1993)
Neurexin III
: extensive alternative splicing generates membrane-bound and soluble forms.
Proc Natl Acad Sci USA
90:6410-6414[Abstract/Free Full Text]. -
Ushkaryov YA,
Petrenko AG,
Geppert M,
Südhof TC
(1992)
Neurexins: synaptic cell surface proteins related to the
-latrotoxin receptor and laminin.
Science
257:50-56[Abstract/Free Full Text]. -
Ushkaryov YA,
Hata Y,
Ichtchenko K,
Moomaw C,
Afendis S,
Slaughter CA,
Südhof TC
(1994)
Conserved domain structure of
-neurexins. Unusual cleaved signal sequences in receptor-like neuronal cell-surface proteins.
J Biol Chem
269:11987-11992[Abstract/Free Full Text]. -
Wang H,
Kunkel DD,
Martin TM,
Schwartzkroin PA,
Tempel BL
(1993)
Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons.
Nature
365:75-79[Medline].
This article has been cited by other articles:

|
 |

|
 |
 
H. Taniguchi, L. Gollan, F. G. Scholl, V. Mahadomrongkul, E. Dobler, N. Limthong, M. Peck, C. Aoki, and P. Scheiffele
Silencing of Neuroligin Function by Postsynaptic Neurexins
J. Neurosci.,
March 14, 2007;
27(11):
2815 - 2824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rissone, M. Monopoli, M. Beltrame, F. Bussolino, F. Cotelli, and M. Arese
Comparative Genome Analysis of the Neurexin Gene Family in Danio rerio: Insights into Their Functions and Evolution
Mol. Biol. Evol.,
January 1, 2007;
24(1):
236 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-P. Hsueh and M. Sheng
Regulated Expression and Subcellular Localization of Syndecan Heparan Sulfate Proteoglycans and the Syndecan-Binding Protein CASK/LIN-2 during Rat Brain Development
J. Neurosci.,
September 1, 1999;
19(17):
7415 - 7425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Einheber, G. Zanazzi, W. Ching, S. Scherer, T. A. Milner, E. Peles, and J. L. Salzer
The Axonal Membrane Protein Caspr, a Homologue of Neurexin IV, Is a Component of the Septate-like Paranodal Junctions That Assemble during Myelination
J. Cell Biol.,
December 15, 1997;
139(6):
1495 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Irie, Y. Hata, M. Takeuchi, K. Ichtchenko, A. Toyoda, K. Hirao, Y. Takai, T. W. Rosahl, and T. C. Südhof
Binding of Neuroligins to PSD-95
Science,
September 5, 1997;
277(5331):
1511 - 1515.
[Abstract]
[Full Text]
|
 |
|
|

|